Hee‐Jung Ban

433 total citations
25 papers, 338 citations indexed

About

Hee‐Jung Ban is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Hee‐Jung Ban has authored 25 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Hee‐Jung Ban's work include Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (5 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Hee‐Jung Ban is often cited by papers focused on Lung Cancer Treatments and Mutations (13 papers), Lung Cancer Research Studies (5 papers) and Lung Cancer Diagnosis and Treatment (5 papers). Hee‐Jung Ban collaborates with scholars based in South Korea. Hee‐Jung Ban's co-authors include Young‐Chul Kim, In‐Jae Oh, Kyu‐Sik Kim, Yu‐Il Kim, Yong Soo Kwon, Sung Chul Lim, Jisun Oh, Sung‐Ja Ahn, Taek‐Keun Nam and Woong‐Ki Chung and has published in prestigious journals such as Clinical Cancer Research, Lung Cancer and Cancer Chemotherapy and Pharmacology.

In The Last Decade

Hee‐Jung Ban

24 papers receiving 330 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hee‐Jung Ban South Korea 10 230 109 48 40 40 25 338
Mau Ern Poh Malaysia 9 155 0.7× 50 0.5× 102 2.1× 36 0.9× 24 0.6× 31 246
Takehiro Hasegawa Japan 10 118 0.5× 55 0.5× 69 1.4× 55 1.4× 80 2.0× 24 369
Luis Villa Colombia 6 64 0.3× 195 1.8× 96 2.0× 31 0.8× 19 0.5× 9 310
Chineme Enyioha United States 7 282 1.2× 139 1.3× 53 1.1× 41 1.0× 24 0.6× 18 484
M Lavandier France 8 162 0.7× 111 1.0× 23 0.5× 33 0.8× 12 0.3× 27 328
Muna Albayaty United Kingdom 11 74 0.3× 37 0.3× 83 1.7× 49 1.2× 33 0.8× 27 301
Kosuke Hamai Japan 9 203 0.9× 84 0.8× 41 0.9× 16 0.4× 47 1.2× 32 279
Arlan D. Martin United States 12 77 0.3× 45 0.4× 49 1.0× 83 2.1× 114 2.9× 19 292
Juan Miguel Sánchez Nieto Spain 10 115 0.5× 37 0.3× 155 3.2× 47 1.2× 41 1.0× 21 375
Ahmet Emin Erbaycu Türkiye 10 106 0.5× 39 0.4× 46 1.0× 33 0.8× 18 0.5× 50 251

Countries citing papers authored by Hee‐Jung Ban

Since Specialization
Citations

This map shows the geographic impact of Hee‐Jung Ban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hee‐Jung Ban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hee‐Jung Ban more than expected).

Fields of papers citing papers by Hee‐Jung Ban

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hee‐Jung Ban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hee‐Jung Ban. The network helps show where Hee‐Jung Ban may publish in the future.

Co-authorship network of co-authors of Hee‐Jung Ban

This figure shows the co-authorship network connecting the top 25 collaborators of Hee‐Jung Ban. A scholar is included among the top collaborators of Hee‐Jung Ban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hee‐Jung Ban. Hee‐Jung Ban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shin, Hong‐Joon, Cheol‐Kyu Park, Tae-Ok Kim, et al.. (2016). Different characteristics associated with intensive care unit transfer from the medical ward between patients with acute exacerbations of chronic obstructive pulmonary disease with and without pneumonia. Journal of Thoracic Disease. 8(6). 1121–1131. 2 indexed citations
2.
Ahn, Sung‐Ja, Young‐Chul Kim, Kyu‐Sik Kim, et al.. (2015). Predictive factors for survival and correlation to toxicity in advanced Stage III non-small cell lung cancer patients with concurrent chemoradiation. Japanese Journal of Clinical Oncology. 46(2). hyv174–hyv174. 10 indexed citations
3.
Kim, Yu‐Il, Seong Hoon Yoon, Hee‐Jung Ban, et al.. (2014). Prevalence of Chronic Sputum and Associated Factors in Korean Adults. Journal of Korean Medical Science. 29(6). 825–825. 3 indexed citations
4.
Ban, Hee‐Jung, Kyu‐Sik Kim, In‐Jae Oh, et al.. (2014). Efficacy and safety of docetaxel plus oxaliplatin as a first‐line chemotherapy in patients with advanced or metastatic non‐small cell lung cancer. Thoracic Cancer. 5(6). 525–529. 3 indexed citations
5.
Ahn, Sung‐Ja, Chan Choi, Yoo Duk Choi, et al.. (2014). Microarray analysis of gene expression in lung cancer cell lines treated by fractionated irradiation.. PubMed. 34(9). 4939–48. 11 indexed citations
6.
Oh, In‐Jae, Kyu‐Sik Kim, Young‐Chul Kim, et al.. (2013). A phase III concurrent chemoradiotherapy trial with cisplatin and paclitaxel or docetaxel or gemcitabine in unresectable non-small cell lung cancer: KASLC 0401. Cancer Chemotherapy and Pharmacology. 72(6). 1247–1254. 17 indexed citations
7.
Lee, Jeong‐Won, W.J. Kim, Chan-Woo Park, et al.. (2013). Endotracheal Tuberculous Granuloma Formation Following Endobronchial Ultrasound Transbronchial Needle Aspiration. Internal Medicine. 52(11). 1207–1210. 6 indexed citations
8.
Kang, Hyun‐Wook, W. Ray Kim, Yun‐Hyeon Kim, et al.. (2013). Prevalence of non‐calcified pulmonary nodules in screening chest computed tomography. Thoracic Cancer. 4(4). 405–409. 2 indexed citations
9.
Oh, Jisun, Yu‐Il Kim, Hee‐Jung Ban, et al.. (2013). Differences in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnea scores: a cross-sectional analyses. BMC Pulmonary Medicine. 13(1). 35–35. 80 indexed citations
10.
Kim, Eun Young, Hee‐Jung Ban, In‐Jae Oh, et al.. (2013). Repeated Favorable Responses to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in a Case of Advanced Lung Adenocarcinoma. Tuberculosis & respiratory diseases. 74(3). 129–129. 1 indexed citations
11.
Kim, Tae-Ok, In‐Jae Oh, Hyun‐Wook Kang, et al.. (2012). Temozolomide-Associated Bronchiolitis Obliterans Organizing Pneumonia Successfully Treated with High-Dose Corticosteroid. Journal of Korean Medical Science. 27(4). 450–450. 7 indexed citations
12.
Kim, Kyu‐Sik, In‐Jae Oh, Hee‐Jung Ban, et al.. (2012). Comparison of docetaxel/cisplatin dosages of 75/60 and 60/60 mg/m2 for the treatment of non-small cell lung cancer. Experimental and Therapeutic Medicine. 4(2). 317–322. 8 indexed citations
13.
Oh, In‐Jae, Hee‐Jung Ban, Kyu‐Sik Kim, & Young‐Chul Kim. (2012). Retreatment of gefitinib in patients with non-small-cell lung cancer who previously controlled to gefitinib: A single-arm, open-label, phase II study. Lung Cancer. 77(1). 121–127. 63 indexed citations
14.
Ban, Hee‐Jung, et al.. (2012). Abstract B43: SNP Q787Q of EGFR gene and efficacy of EGFR-TKI in patients with non-small cell lung cancer. Clinical Cancer Research. 18(3_Supplement). B43–B43. 1 indexed citations
15.
Yu, Jinming, Boram Lee, Sunmi Ju, et al.. (2011). Proportion and characteristics of transient nodules in a retrospective analysis of pulmonary nodules. Thoracic Cancer. 3(3). 224–228. 8 indexed citations
16.
Oh, In‐Jae, Hee‐Jung Ban, Kyu‐Sik Kim, et al.. (2011). Response to gemcitabine–platinum chemotherapy by single nucleotide polymorphisms of RRM1 and ERCC1 genes in patients with non‐small‐cell lung cancer. Thoracic Cancer. 3(1). 19–26. 2 indexed citations
17.
Oh, In‐Jae, Yu‐Il Kim, Hee‐Jung Ban, et al.. (2011). Can Pleuropulmonary Paragonimiasis be Cured by Only the 1st Set of Chemotherapy? Treatment Outcome and Clinical Features of Recently Developed Pleuropulmonary Paragonimiasis. Internal Medicine. 50(13). 1365–1370. 21 indexed citations
18.
Shin, Hong‐Joon, Hee‐Jung Ban, Yong Soo Kwon, et al.. (2011). Comparison of Therapeutic Efficacy of Gefitinib and Erlotinib in Patients with Squamous Cell Lung Cancer. Tuberculosis & respiratory diseases. 71(1). 15–15. 5 indexed citations
19.
Kim, Yu‐Il, Seung‐Jung Kee, Hee‐Jung Ban, et al.. (2010). The Impact of the 2007 ATS/IDSA Diagnostic Criteria for Nontuberculous Mycobacterial Disease on the Diagnosis of Nontuberculous Mycobacterial Lung Disease. Respiration. 82(2). 124–129. 15 indexed citations
20.
Kim, Eun Young, Hee‐Jung Ban, In‐Jae Oh, et al.. (2010). Risk Factors for Fatal Hemoptysis after Concurrent Chemoradiation Therapy in Patients with Non-Small Cell Lung Carcinoma. 46(1). 19–19. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026